
|Videos|June 6, 2017
Frontline Bostunib vs Imatinib in Chronic Myeloid Leukemia
Author(s)Jorge E. Cortes, MD
This video highlights results of the BFORE trial, which tested bosutinib vs imatinib in newly diagnosed chronic myeloid leukemia patients.
Advertisement
In this video, Jorge E. Cortes, MD, of the University of Texas MD Anderson Cancer Center in Houston, discusses results of the BFORE trial, which tested bosutinib vs imatinib in newly diagnosed chronic myeloid leukemia patients.
Cortes presented the results of the study (
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
Tazemetostat Withdrawn From Follicular Lymphoma, Sarcoma Markets
2
Treating Young Patients With Colorectal Cancer: Talking With a Surgeon
3
FDA Issues CRL for Retifanlimab/Chemotherapy in Metastatic NSCLC
4
Dismantling Barriers to Early Adoption of Bispecifics in Multiple Myeloma
5
























































